Skip to main
VTR

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas's diversified healthcare portfolio comprises nearly 1,400 properties, which positions the company favorably in the robust healthcare real estate sector, covering senior housing, medical office spaces, hospitals, life sciences, and skilled nursing care. The geographical diversification, including properties in mature healthcare markets like Canada and the UK, enhances Ventas's investment potential, mitigating risks associated with any single market while seeking further opportunities in similar environments. Additionally, the company's mortgage and loan holdings, while contributing a modest fraction to net operating income, represent a strategic move to diversify revenue streams, complementing its core real estate operations.

Bears say

Ventas faces potential challenges due to reductions in Medicare and Medicaid reimbursements, which could adversely affect rent coverage ratios and lead to rent restructuring or reductions. Additionally, the company's revenue exposure to individual tenants exceeding 5% increases the risk associated with tenant concentration, potentially exacerbating financial impacts from reimbursement changes. Furthermore, the healthcare REIT sector, characterized by bond-like cash flows, is likely to underperform in a rising interest rate environment, posing further risks to Ventas's growth and access to capital markets.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $79.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $79.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.